These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 25529558)

  • 1. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
    Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
    Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).
    Souza-Fonseca-Guimaraes F; Parlato M; de Oliveira RB; Golenbock D; Fitzgerald K; Shalova IN; Biswas SK; Cavaillon JM; Adib-Conquy M
    J Biol Chem; 2013 Apr; 288(15):10715-21. PubMed ID: 23443666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation.
    Temizoz B; Hioki K; Kobari S; Jounai N; Kusakabe T; Lee MSJ; Coban C; Kuroda E; Ishii KJ
    Int Immunol; 2022 Jul; 34(7):353-364. PubMed ID: 35419609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.
    Deb P; Dai J; Singh S; Kalyoussef E; Fitzgerald-Bocarsly P
    J Immunol; 2020 Jul; 205(1):223-236. PubMed ID: 32471881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
    Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
    Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan.
    Kobiyama K; Temizoz B; Kanuma T; Ozasa K; Momota M; Yamamoto T; Aoshi T; Kuroda E; Ishii KJ
    Eur J Immunol; 2016 May; 46(5):1142-51. PubMed ID: 26786557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic d-type CpG-oligonucleotides induce a type I interferon response by activating the cGAS-STING signaling pathway.
    Bode C; Poth JM; Fox M; Schulz S; Klinman DM; Latz E; Steinhagen F
    Eur J Immunol; 2021 Jul; 51(7):1686-1697. PubMed ID: 33860535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response.
    Kocabas BB; Almacioglu K; Bulut EA; Gucluler G; Tincer G; Bayik D; Gursel M; Gursel I
    J Control Release; 2020 Dec; 328():587-595. PubMed ID: 32971199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.
    Kitahata Y; Kanuma T; Hayashi M; Kobayashi N; Ozasa K; Kusakabe T; Temizoz B; Kuroda E; Yamaue H; Coban C; Yamamoto T; Kobiyama K; Aoshi T; Ishii KJ
    Oncotarget; 2016 Aug; 7(31):48860-48869. PubMed ID: 27384490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses.
    Yang JX; Tseng JC; Tien CF; Lee CY; Liu YL; Lin JJ; Tsai PJ; Liao HC; Liu SJ; Su YW; Hsu LC; Chen JK; Huang MH; Yu GY; Chuang TH
    Int J Biol Sci; 2023; 19(9):2897-2913. PubMed ID: 37324951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist.
    Kobiyama K; Aoshi T; Narita H; Kuroda E; Hayashi M; Tetsutani K; Koyama S; Mochizuki S; Sakurai K; Katakai Y; Yasutomi Y; Saijo S; Iwakura Y; Akira S; Coban C; Ishii KJ
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3086-91. PubMed ID: 24516163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function.
    Imanishi T; Unno M; Kobayashi W; Yoneda N; Matsuda S; Ikeda K; Hoshii T; Hirao A; Miyake K; Barber GN; Arita M; Ishii KJ; Akira S; Saito T
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30683688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
    Kerkmann M; Rothenfusser S; Hornung V; Towarowski A; Wagner M; Sarris A; Giese T; Endres S; Hartmann G
    J Immunol; 2003 May; 170(9):4465-74. PubMed ID: 12707322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
    Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
    FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
    Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.
    Rothenfusser S; Hornung V; Krug A; Towarowski A; Krieg AM; Endres S; Hartmann G
    Eur J Immunol; 2001 Dec; 31(12):3525-34. PubMed ID: 11745372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
    Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
    PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.